Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-07-23Clinical Trial Update: UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating UCN-01 in combination with Topotecan for recurrent, persistent, or progressive advanced ovarian epitheli…
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Study of Bevacizumab/Doxil in Treatment of Platinum-Resistant/Refractory Ovarian Cancer (CA) [Phase 2]
Phase 2 study evaluating bevacizumab in combination with Doxil for platinum-resistant/refractory ovarian cancer has completed; results were …
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor
A completed clinical trial evaluated granulocyte-colony stimulating factor (G-CSF) for prevention of chemotherapy-induced febrile neutropeni…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian Tumors [Phase 2]
A Phase 2 trial evaluating consolidation therapy with bevacizumab (Avastin) with or without erlotinib after induction chemotherapy in advanc…
-
CLINICAL_TRIALS trial_result · 2015-07-02Clinical Trial Update: Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer [NA]
A completed clinical trial evaluating whole-body diffusion MRI for staging, predicting response, and detecting recurrence in ovarian cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian [Phase 1]
Phase 1 trial update of neoadjuvant chemotherapy with weekly paclitaxel, carboplatin, and bevacizumab for ovarian and related cancers; study…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the effect of HER2 activation on Pertuzumab in subjects with advanced ovarian cancer; the study has completed and r…
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Maintenance Treatment for Ovarian Carcinoma in Remission by an Antiangiogenic Treatment Strategy [Phase 2]
A Phase 2 trial evaluating maintenance antiangiogenic therapy for ovarian cancer in remission was terminated.
-
CLINICAL_TRIALS trial_result · 2015-06-17Clinical Trial Update: Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer [Phase 2]
Phase 2 trial update of carboplatin and paclitaxel in elderly women with newly diagnosed ovarian, primary peritoneal, or related cancers; st…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating rhuMab 2C4 with gemcitabine in ovarian, primary peritoneal, and fallopian tube cancers has completed enr…
-
CLINICAL_TRIALS trial_result · 2015-06-10Clinical Trial Update: Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status [Phase 1, Phase 2]
This clinical trial update reports on a completed Phase 1/2 study of veliparib plus topotecan in relapsed ovarian cancer patients with negat…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Strength Training Study for Survivors of Breast and Gynecologic Cancer [NA]
A completed clinical trial update on a strength training program for survivors of breast cancer and gynecologic cancers, sponsored by the No…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Fosaprepitant Versus Aprepitant in the Prevention of Chemotherapy Induced Nausea and Vomiting [Phase 4]
Phase 4 trial comparing fosaprepitant (IV) to aprepitant for prevention of chemotherapy-induced nausea and vomiting; results were posted in …
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats [Phase 2]
Open-label Phase 2 trial assessing efficacy and safety of olaparib in patients with BRCA1/BRCA2 mutations across ovarian, breast, prostate, …
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer [Phase 1]
Phase 1 trial evaluating veliparib with carboplatin and paclitaxel in adults with advanced solid tumors has completed. The study included BR…
-
CLINICAL_TRIALS trial_result · 2015-05-21Clinical Trial Update: Pazopanib/Doxil in Adv Relapsed Plat Sensitive or Resistant Ovarian, Fallopian or Primary Peritoneal Adenocarcinoma [Phase 1, Phase 2]
Clinical trial update for pazopanib/doxorubicin in relapsed platinum-sensitive or resistant ovarian, fallopian tube, or primary peritoneal a…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Ph II Study of Wkly Topotecan + Bevacizumab in Plat. Resistant/Recurrent Gyn Cancers [Phase 2]
Phase 2 trial evaluating weekly topotecan with bevacizumab in platinum-resistant/recurrent gynecologic cancers; the study (including ovarian…
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab with low-dose cyclophosphamide in patients with recurrent ovarian epithelial cancer or primary peritone…
-
CLINICAL_TRIALS trial_result · 2015-05-08Clinical Trial Update: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [Phase 1]
Phase 1 study of polyglutamate paclitaxel in combination with carboplatin for ovarian epithelial, fallopian tube, and primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2015-05-05Clinical Trial Update: Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer [Phase 2, Phase 3]
A phase 2/3 trial evaluated the combination of saracatinib with paclitaxel in platinum-resistant ovarian cancer, including fallopian tube an…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of gemcitabine, carboplatin, and bevacizumab for ovarian cancer, fallopian tube cancer, or…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Imatinib Mesylate in Treating Patients With Refractory or Relapsed Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer, or Ovarian Low Malignant Potential Tumor [Phase 2]
Phase 2 clinical trial update evaluating imatinib mesylate in patients with refractory or relapsed ovarian epithelial cancer, fallopian tube…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Advanced Cancer [Phase 1]
A Phase 1 trial of immunotoxin therapy in patients with advanced cancers has completed, with results spanning several gynecologic and non-gy…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial of an immunotoxin therapy in patients with advanced solid tumors has completed, spanning eight cancer types including cervical…
-
CLINICAL_TRIALS trial_result · 2015-04-29Clinical Trial Update: Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer [Phase 1]
Phase 1 clinical trial evaluating gene therapy and biological therapy for ovarian cancer has completed. The study explored safety and prelim…